Martin Fabian Bachmann
Martin Fabian Bachmann (* December 15, 1967 in Winterthur, Schweiz) is professor for immunology at the University of Bern.
Leben[edit]
Martin Fabian Bachmann made a name for himself in the field of therapeutic vaccines and virus-like particles. He is Professor of Immunology at the University of Bern, Switzerland, University of Oxford, UK and Director of the International Immunology Institute of Anhui University, Hefei, China. Martin Bachmann is the founder and co-founder of several biotech companies active in the field of therapeutic vaccines in humans (Saiba GmbH, HealVAX GmbH and DeepVax GmbH) and animals (Hypopet AG, Evax AG). Martin Bachmann began his research career in the field of anti-viral immune responses in the laboratory of Nobel laureate Rolf M. Zinkernagel (1991-1995), before joining Pam Ohashi in Toronto (1995-1997) and becoming Principle Investigator at the Basel Institute for Immunology (1997-2000).
In a next step, Bachmann focused his research on vaccine development and led the research for more than 10 years at Cytos AG in Schlieren-Zurich, Switzerland (2000-2012). During this time, clinical proof-of-concepts have been achieved in humans in several indications, including a vaccine for high blood pressure.[1] smoking[2], allergy[3] and asthma[4]. He has developed a vaccine against Alzheimer's disease which now is in a registration study with Novartis. From 2012 on, Bachmann returned to academia and continued to focus on therapeutic vaccines based on virus-like particles. In collaboration with Evax AG and Hypopet AG, successful proof-of-concepts for therapeutic vaccines against insect sting allergy in horses[5] and atopic dermatitis in dogs[6] have been obtained. It was also possible to use a vaccine to render cats hypoallergenic, in order to facilitate living together with allergic owners[7]
Awards[edit]
Bachmann received 1991 for his Master thesis at ETH Zürich entitled "On the influence of cell adhesion molecules on the adheseviness of the extracellular matrix" the ETH Silver Medal. His PhD-work “On the role of antigen organization on driving B cell responses” was also awarded with the ETH Silver Medal in 1995. In 1998 he was rewarded with the Pfizer Preis für Immunologie. For work performed at Cytos (2004) und Hypopet (2013) he was twice awarded with the Swiss Technology Award.
External links[edit]
 |
Wikimedia Commons has media related to [[commons:Lua error in Module:WikidataIB at line 466: attempt to index field 'wikibase' (a nil value).|Lua error in Module:WikidataIB at line 466: attempt to index field 'wikibase' (a nil value).]]. |
- Prof. Dr. Martin F. Bachmann at the Universität Bern (www.unibe.ch)
- Prof. Dr. Martin F. Bachmann am Inselspital Universitätsspital Bern
- Scientific Advisory Board Biotechnology Institute Thurgau at the University of Konstanz (www.bitg.ch)
- Prof. Dr. Martin F. Bachmann CSO and Hyponet (www.hypopet.ch)
- Visiting professor an der ETH Zürich
- Associate Professor of Immunology an der University of Oxford
References[edit]
- ↑ [1] Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
- ↑ [2] A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial
- ↑ [3] Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
- ↑ [4] The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
- ↑ [5] Treating insect-bite hypersensitivity in horses with active vaccination against IL-5
- ↑ [6] Vaccination against IL-31 for the treatment of atopic dermatitis in dogs
- ↑ [7] Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects
| Martin Fabian Bachmann | |
|---|---|
| Born | December 15, 1967 Winterthur |
| 💼 Occupation | |
| Twitter= | |
This article "Martin Fabian Bachmann" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Martin Fabian Bachmann. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
